Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
liothyronine sodium
|
| gptkbp:ATCCode |
H03AA02
|
| gptkbp:chemicalClass |
hormone
|
| gptkbp:contraindication |
gptkb:thyrotoxicosis
uncorrected adrenal insufficiency |
| gptkbp:FDAApproved |
yes
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cytomel
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
synthetic T3 hormone
|
| gptkbp:pregnancyCategory |
A (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:arrhythmia
weight loss nervousness palpitations |
| gptkbp:usedFor |
hypothyroidism
myxedema coma |
| gptkbp:bfsParent |
gptkb:liothyronine
|
| gptkbp:bfsLayer |
8
|